Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. - Test2 - elhamkhani - TriplyDB

Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia.

Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia.

http://www.wikidata.org/entity/Q35133174

about

Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response The influence of innate and adaptive immune responses on atherosclerosis Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice Regulation of Adaptive Immunity in Health and Disease by Cholesterol Metabolism Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis.CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response.Imbalance between IL-17A-producing cells and regulatory T cells during ischemic stroke.Increased membrane cholesterol in lymphocytes diverts T-cells toward an inflammatory response Lymphocytes in atherosclerosis.Cholesterol lowering modulates T cell function in vivo and in vitro Gr-1⁺CD11b⁺ immature myeloid cells (IMC) promote resistance of pro-inflammatory T cells to suppression by regulatory T cells in atherosclerotic Apo E- deficient mice.Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment.Immune modulation of atherosclerosis Lymphocyte migration into atherosclerotic plaque.Peak inflammation in atherosclerosis, primary biliary cirrhosis and autoimmune arthritis is counter-intuitively associated with regulatory T cell enrichment.How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?Animal models of atherosclerosis.Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: a longitudinal study during atorvastatin treatment Plasmacytoid dendritic cells in atherosclerosis.microRNA-181a represses ox-LDL-stimulated inflammatory response in dendritic cell by targeting c-Fos.Adaptive immunity in atherogenesis: new insights and therapeutic approaches.Endothelial NADPH oxidase 4 protects ApoE-/- mice from atherosclerotic lesions The role of the vascular dendritic cell network in atherosclerosis.2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in Atherosclerosis High density lipoprotein biogenesis, cholesterol efflux, and immune cell function.Hyperlipidemia Alters Regulatory T Cell Function and Promotes Resistance to Tolerance Induction Through Costimulatory Molecule Blockade.Microdomains, Inflammation, and Atherosclerosis.Dendritic cells and regulatory T cells in atherosclerosis.Inflammation and atherosclerosis: direct versus indirect mechanisms Molecular biology of atherosclerosis.Treating atherosclerosis with regulatory T cells.ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis.Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.Impact of environmental factors on alloimmunity and transplant fate.Immune-mediated mechanisms of atherosclerosis and implications for the clinic.High density lipoproteins selectively promote the survival of human regulatory T cells.Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis?Impact of hyperlipidemia on alloimmunity.Interferon Control of the Sterol Metabolic Network: Bidirectional Molecular Circuitry-Mediating Host Protection.The immunology of atherosclerosis.

P2860

Q26778275-1D0E8CD7-0699-45D1-8216-78A77B4DE328 Q27000370-0285274A-066F-4C4C-8D55-DF1F217AADE8 Q27335174-2DBADA85-1B17-4308-A4D3-0BDCE7BB0B3F Q28083961-4E5C78C0-8528-4F3C-BB93-36AC70D0AEAD Q30355065-168CAF20-EAED-4CA7-A236-E52106B7E02E Q30426856-971FE1C2-7593-4A79-BB14-2956FCE85697 Q33759877-3F02B472-1FAD-4580-8528-7A33B0C0A08C Q34313939-B8E31ABF-DECD-4061-AD1C-A7734346CEC8 Q35082438-BAFB57AF-F6FD-4F4F-A855-66CB65F2A307 Q35125249-320E9F63-49E2-4EA9-80F8-C23D16998A79 Q35289139-06EDAC8A-2348-4635-84DF-42D49D0199BA Q35552966-7641E550-FC33-484C-8147-46B0B8DCDBC7 Q35599691-8C754630-9CC1-4427-87BF-AEF2EA73F271 Q35600904-FE41548B-547F-435D-AB06-87DFC1B0204E Q35687041-D836BEAA-F9AC-45E1-B65C-F8D9D8F47BA8 Q35738372-167C58AD-EBB1-4386-AD21-0C985E6D7B4E Q35903298-5F710A43-D643-49E8-8B43-D3D4831D9B45 Q35907898-BB1F7E8F-13A6-416C-AAC6-29428D91C980 Q36064574-479DB398-C74D-40E1-97C4-211F34B56956 Q36302743-D76FFE13-4A5F-4992-8FB6-5121AE5055BF Q36497196-4DDE1BFD-7C26-4045-B8CD-C41B0191F1C5 Q36664698-50C3AE2B-FEFA-4270-ACCD-BD506DE591BE Q37050929-05DD0F37-CBA8-45CC-B8DA-90E1ACF0B577 Q37146276-4B4EEDD2-F819-4C8D-865C-9DEE926F5D5B Q37221779-EE21656F-6C96-4082-940C-40D452118C99 Q37444403-0A3C90C6-4D31-47B7-BD2D-6471658406EE Q37623996-7DE71564-4E71-40A2-95B4-AB6C95443D16 Q38023274-6061DC1C-EA78-4155-9FA7-9D845710BC60 Q38077322-7D1941F9-264B-4158-B6E4-71BD9F6F64A9 Q38125279-55D31FA5-5453-44CC-BB00-9E382E7B08F1 Q38270134-8CECD65C-B4E9-422F-81FC-630CCE8C4623 Q38737500-A4481B81-7B9A-4859-B953-B87FB2B1EE67 Q38774904-D2CD59C7-8EB6-426B-B140-E60B7ECF65BF Q38798599-3DB84C91-3E0C-49AD-9FC5-AAA412AF1922 Q38851472-137C177B-ACFB-477E-BF4C-DCCABE8F578D Q38854617-BA8746F7-9B87-4BF6-9B26-29E75639FC6D Q38888696-01E1EAC9-0E45-4467-94A9-039E16C7F7CD Q39041394-D1967355-5966-471F-B57B-33265457E313 Q39076009-D6BADEF2-077F-4B52-8382-418C88E4F14B Q39230390-1A877F2A-BDB8-482B-BF28-67D61193BEF9

P2860

Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia.

http://www.wikidata.org/entity/Q35133174

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Dynamic changes in regulatory ...... -induced hypercholesterolemia.

@ast

Dynamic changes in regulatory ...... -induced hypercholesterolemia.

@en

type

label

Dynamic changes in regulatory ...... -induced hypercholesterolemia.

@ast

Dynamic changes in regulatory ...... -induced hypercholesterolemia.

@en

prefLabel

Dynamic changes in regulatory ...... -induced hypercholesterolemia.

@ast

Dynamic changes in regulatory ...... -induced hypercholesterolemia.

@en

P1433

Q35133174-EB555B37-35FE-4167-B97E-87CC3D8993BF

P1476

Q35133174-DA7D6C9B-3F0F-47D6-B1DC-B6E69C2591C1

P2093

Q35133174-4AE71E5F-3227-4FC9-BAC7-FEB1FB5AE252

Q35133174-4FF600C0-7D15-428E-99A8-FEF6048867D1

Q35133174-95BF3803-857A-4A0D-9A1A-D501C8C49195

Q35133174-9B206F7D-3C54-45FC-BB09-597D68E31691

Q35133174-BAE5BB75-844D-4D8D-B65A-C108B8FCE6F4

P2860

Q35133174-09F21C80-7CC2-452F-AB88-5130BBF10944

Q35133174-0CF08E2C-BC5A-47DD-A68A-A6D83F052B84

Q35133174-10F5FE0A-F2E9-46EE-B081-5AB0CAF0B797

Q35133174-13E7CDB7-5D58-4480-BD2E-9BC773D3BE1A

Q35133174-16DC2664-0985-48A7-BDD6-1CD4F5F29EBC

Q35133174-19B68814-E4D2-4060-854F-EB80AA2E7A04

Q35133174-1DCC2BF7-5526-4FAD-ACB8-B7E976D1582C

Q35133174-2B750558-CDB6-41FC-AB2F-03AA945FD834

Q35133174-3642B129-8E20-45C0-A6C8-E32C705153EF

Q35133174-36761A97-7E8E-4E09-9F6F-7E85A4FE2C95

P304

Q35133174-B77BCE05-20BE-46C7-B491-53A756A12772

P31

Q35133174-9448644D-EF72-4C3F-AA52-A0DCFB864747

P356

Q35133174-F57451A5-CAAE-40A5-A2B4-862FC71D73E5

P407

Q35133174-A7E89D06-BF4F-4C51-A4FE-AF09924217DB

P433

Q35133174-97CBA276-BCDC-49FA-94A9-24AF59B71C6B

P478

Q35133174-D554D33E-D976-405C-AA71-142CB13FCF28

P577

Q35133174-65D02B0C-DDA1-47C6-ABD5-E9ABAC9CA3E3

P698

Q35133174-6AA20B7E-5A4C-4435-950E-AC6819111A12

P921

Q35133174-52850A21-421A-4AB6-92A7-16F67B2220E4

P932

Q35133174-2FD1F574-E473-471B-B50F-88F2215596F2

P356

CIRCULATIONAHA.110.006411

P1433

P1476

Dynamic changes in regulatory ...... -induced hypercholesterolemia.

@en

P2093

Andrew H Lichtman

http://www.w3.org/2001/XMLSchema#string

De-xiu Bu

http://www.w3.org/2001/XMLSchema#string

Elena Maganto-García

http://www.w3.org/2001/XMLSchema#string

Margarite L Tarrio

http://www.w3.org/2001/XMLSchema#string

Nir Grabie

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

Inflammation, atherosclerosis, and coronary artery disease

Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.

Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent.

Vascular adhesion molecules in atherosclerosis.

Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions

Leukocyte adhesion molecules in atherogenesis.

T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses

P304

185-195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.110.006411

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21690490

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

3145407

http://www.w3.org/2001/XMLSchema#string